Firefly Neuroscience (NASDAQ:AIFF) Trading 1.2% Higher – Still a Buy?

Shares of Firefly Neuroscience, Inc. (NASDAQ:AIFF) were up 1.2% during trading on Tuesday . The company traded as high as $4.39 and last traded at $4.12. Approximately 598,315 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 12,633,725 shares. The stock had previously closed at $4.07.

Firefly Neuroscience Stock Performance

The company has a fifty day moving average price of $4.56.

Institutional Trading of Firefly Neuroscience

A hedge fund recently bought a new stake in Firefly Neuroscience stock. Citadel Advisors LLC purchased a new stake in Firefly Neuroscience, Inc. (NASDAQ:AIFF) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 11,334 shares of the company’s stock, valued at approximately $30,000. Citadel Advisors LLC owned about 0.14% of Firefly Neuroscience as of its most recent filing with the Securities and Exchange Commission. 4.96% of the stock is owned by hedge funds and other institutional investors.

Firefly Neuroscience Company Profile

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.